Centene Corporation is rebuilding its Marketplace business after a difficult 2025, with the segment's health benefits ratio improving to 79.2% in the second quarter of 2026 from 90.6% a year ago, helped by better pricing, moderating medical costs, and a $180 million favorable CMS risk-adjustment reconciliation. Although Marketplace membership fell to about 3.5 million from 5.9 million, the company now expects a 4.5% to 5% pretax margin for 2026, up from a prior 3% outlook, signaling a shift toward profitability over volume. The challenge is sustaining gains amid potential membership attrition from eligibility reviews, but an improved SG&A expense ratio of 6.9% and increased use of technology and AI could provide support. Centene's shares have surged 56.4% year-to-date, and the Zacks Consensus Estimate for 2026 earnings is $4.89 per share, implying 135.1% growth, with the stock carrying a Zacks Rank #1 (Strong Buy).
Centene CorpImproved Marketplace margin and raised 2026 pretax margin outlook to 4.5-5% from 3%.
Elevance Health Inc
UnitedHealth Group Incorporated